entity

Are

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Are: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
17Hypotheses
2Analyses
1Outgoing
2Incoming
19Experiments
2Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Claude Code (Anthropic Agent SDK)

ai_tool · 0 words

Ventral Tegmental Area Dopamine Neurons in Parkinson's Disease

cell · 2730 words

Lateral Preoptic Area (LPOA) Neurons

cell · 2493 words

Hypothalamic Preoptic Area Sleep-Active Neurons

cell · 2013 words

GABAergic Preoptic Area Neurons

cell · 1994 words

Ventral Tegmental Area Glutamatergic Neurons

cell · 1745 words

Outgoing (1)

TargetRelationTypeStr
Inflammatory Mediatorsregulatesprocess0.80

Incoming (2)

SourceRelationTypeStr
NRF2activatesprotein0.90
NFE2L2component_ofgene0.90

Targeting Hypotheses (17)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Senescent Microglia Resolution via Maresins-Senolytics Combi 0.784 neurodegeneration Neuroinflammation resolution mechanisms
age-linked CpG drift is the actionable driver in: Are DNA me 0.754 neurodegeneration Are DNA methylation changes in neurodege
age-linked CpG drift is the actionable driver in: Are age-re 0.753 neurodegeneration Are age-related DNA methylation changes
Near-infrared light therapy stimulates COX4-dependent mitoch 0.742 neurodegeneration Mitochondrial transfer between astrocyte
ATAC-seq accessibility separates causal from compensatory st 0.738 neurodegeneration Are DNA methylation changes in neurodege
ATAC-seq accessibility separates causal from compensatory st 0.738 neurodegeneration Are age-related DNA methylation changes
Endosomal trafficking defects are the common upstream lesion 0.730 neurodegeneration What determines the temporal sequence of
protective chromatin remodeling defines the therapeutic wind 0.720 neurodegeneration Are age-related DNA methylation changes
protective chromatin remodeling defines the therapeutic wind 0.720 neurodegeneration Are DNA methylation changes in neurodege
Microglial TREM2 state determines whether C1q-tagged substra 0.670 neurodegeneration Does C1q function differ based on subcel
Vascular mural cell degeneration precedes and exacerbates pa 0.637 Alzheimer's disease SEA-AD Single-Cell Analysis: Cell-Type V
LYTL and JIP4-dependent lysosomal remodeling may show mutant 0.580 neurodegeneration Do pathogenic LRRK2 mutations amplify vo
Circadian-Gated Maresin Biosynthesis Amplification 0.557 neurodegeneration Neuroinflammation resolution mechanisms
Disease-Elevated CHI3L1/CHIT1 Chitinases Are Biomarkers and 0.500 ALS What are the mechanisms by which microgl
Poorly lipidated APOE4 particles are preferentially routed t 0.340 molecular biology Does APOE4's reduced lipid-binding direc
Rare TREM2-TYROBP pathway variants complement standard PRS b 0.000 Late-onset Alzheimer's disease Polygenic Risk Score Analysis for Late-O
Convergent NF-κB enhancers across diverse priming stimuli sh 0.000 Alzheimer's disease Do different priming stimuli require dis

Mentioning Analyses (2)

Scientific analyses that reference this entity

Neuroinflammation resolution mechanisms and pro-resolving mediators

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.784

Autophagy-lysosome pathway convergence across neurodegenerative diseases

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.900

Experiments (19)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Proposed experiment from debate on Senolytics targeting p16/p21+ senes falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%? clinical Alzheimer's Disease 0.400 0.50 human proposed $7,500,000
cGAS-STING Pathway Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,100,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the validation Alzheimer's Disease 0.400 0.50 human proposed $2,960,000
Microglial Contributions to Huntington's Disease Pathogenesis validation Neuroinflammation 0.400 0.50 human proposed $2,960,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship validation Alzheimer's Disease 0.400 0.50 human proposed $3,000,000
s:** - Test MCU overexpression specifically in layer II neurons in hea falsification Neurodegeneration 0.400 0.50 mouse proposed $200,000
Proposed experiment from debate on Mitochondrial transfer between astr falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso validation Parkinson's Disease 0.400 0.50 human proposed $3,000,000
Ferroptosis Validation in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
GLP-1 Agonist Neuroprotection Mechanism in PD clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
Cytochrome Therapeutics clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Peroxisomal Dysfunction Validation in Parkinson's Disease validation Parkinson's Disease 0.400 0.50 human proposed $2,280,000
Prodromal Parkinson's Disease Biomarker Development — Early Detection clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
Synaptic Mitochondrial Resilience Enhancement for Parkinson's Disease validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
Wilson Disease Neurodegeneration: Mechanism and Therapeutic Response clinical Neurodegeneration 0.400 0.50 human proposed $7,500,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] Yu CH, Davidson S, Harapas CR, Hilton JB Cell 2020 2
Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the S [PMID:37738560] Justice JN, Leng XI, LeBrasseur NK, Tchk J Gerontol A Biol Sci Med Sci 2024 1
Increased mitophagy protects cochlear hair cells from aminoglycoside-induced dam [PMID:35471096] Zhang Y, Fang Q, Wang H, Qi J, Sun S, Li Autophagy 2023 1
Sex differences in autophagy-mediated diseases: toward precision medicine. [PMID:32264724] Shang D, Wang L, Klionsky DJ, Cheng H, Z Autophagy 2021 1
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populatio [PMID:33144684] He D, Wang D, Lu P, Yang N, Xue Z, Zhu X Oncogene 2021 1
BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains. [PMID:32722981] Wu X, Zheng Y, Liu M, Li Y, Ma S, Tang W Autophagy 2021 1
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells [PMID:26657143] Chang J, Wang Y, Shao L, Laberge RM, Dem Nat Med 2016 1
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. [PMID:25754370] Zhu Y, Tchkonia T, Pirtskhalava T, Gower Aging Cell 2015 1
SIRT5 regulation of ammonia-induced autophagy and mitophagy. [PMID:25700560] Polletta L, Vernucci E, Carnevale I, Arc Autophagy 2015 1
Genome-wide methylation profiles reveal quantitative views of human aging rates. [PMID:23177740] Hannum G, Guinney J, Zhao L, Zhang L, Hu Mol Cell 2013 1
PRKAB2 as a tumor suppressor in renal cell carcinoma: inhibiting mitophagy via t [PMID:41612594] Chen K, Zhang Y, Ruan H, Wei Z, Wang K, Autophagy 2026 0
ROS-responsive nanogels for brain targeted delivery of icariin in the treatment [PMID:41197818] ["Li X", "Huang J", "Zhou Y", "Chen X", International journal of pharm 2026 0
Single-Cell RNA Sequencing and Network Pharmacology Reveal the Potential Role of [PMID:41610872] ["Niu J", "Wang L", "Qi J", "Lu G"] The journal of gene medicine 2026 0
Integrated Profiling of DEHP-Induced Hippocampal Neurotoxicity in Adult Female R [PMID:41600627] Bai J, Li J, Tang L, Sun W, Gao F, Zhang Toxics 2026 0
Senolytic elimination of therapy-induced senescent cells by ABT-263 improves che [PMID:41423036] Zhang D, Zhu J, Zou R, Zhang H, Yu BP, L Biochemical pharmacology 2026 0
Functional and Molecular Characterization of Melamine-Induced Disruption of Huma [PMID:41596180] ["Luongo F", "Annunzi E", "Ponchia R", " Antioxidants (Basel, Switzerla 2026 0
Comprehensive assessment of the genomic stability of human induced pluripotent s [PMID:41877289] Zhang K, Na T, Jia C, Yuan X, Guo M, Yan Stem cell research & therapy 2026 0
Exploring the lactate-metabolism related characteristics during the development [PMID:41815173] Wang C, Zhang R, Li S, Kang Z, Xia S, Li Translational cancer research 2026 0
Characterization of the Direct and Indirect Inhibition of Apoptosis by Full-Leng [PMID:41589352] Elsner C, Epasto LM, Cieren A, Gendreizi Chembiochem : a European journ 2026 0
Developmental toxicity of carboxylated microplastics in zebrafish mediated by mi [PMID:41265820] ["Li Y", "Ni Y", "Dong C", "Zhang J", "G Environmental pollution (Barki 2026 0

Debates (2)

Multi-agent debates referencing this entity

Multiple NDDs converge on autophagy-lysosome dysfunction. Are there universal th

closed · Rounds: 4 · Score: 0.90 · 2026-04-06

SPMs (resolvins, protectins, maresins) from omega-3s may promote inflammation re

closed · Rounds: 4 · Score: 0.83 · 2026-04-06

Related Research

Hypotheses and analyses mentioning Are in their description or question text

ATAC-seq accessibility separates causal from compensatory states in: Are age-rel

Score: 0.738 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada

Endosomal trafficking defects are the common upstream lesion linking APP process

Score: 0.730 · neurodegeneration · 2026-04-25

AD-risk trafficking defects in SORL1/BIN1/PICALM/retromer may generate parallel early outputs: amyloidogenic APP sorting

protective chromatin remodeling defines the therapeutic window for: Are age-rela

Score: 0.720 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell meth

protective chromatin remodeling defines the therapeutic window for: Are DNA meth

Score: 0.720 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell meth

Microglial TREM2 state determines whether C1q-tagged substrates are cleared adap

Score: 0.670 · neurodegeneration · 2026-04-25

This hypothesis reconciles conflicting C1q phenotypes by placing receiver-cell state downstream of a common upstream C1q

Vascular mural cell degeneration precedes and exacerbates parenchymal pathology

Score: 0.637 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Vascular mural cell degeneration precedes and exacerbates parenchymal pathology starts from the

LYTL and JIP4-dependent lysosomal remodeling may show mutant-selective amplifica

Score: 0.580 · neurodegeneration · 2026-04-24

A more mechanistic but less translationally mature possibility is that G2019S does not strongly alter total phospho-Rab

Circadian-Gated Maresin Biosynthesis Amplification

Score: 0.557 · neurodegeneration · 2026-04-02

## Mechanistic Overview Circadian-Gated Maresin Biosynthesis Amplification starts from the claim that modulating ALOX12

Disease-Elevated CHI3L1/CHIT1 Chitinases Are Biomarkers and Partial Compensators

Score: 0.500 · ALS · 2026-04-26

Poorly lipidated APOE4 particles are preferentially routed through LDLR/LRP1 int

Score: 0.340 · molecular biology · 2026-04-24

This is the weakest mechanistic proposal. It attempts to connect extracellular apoE particle quality to intracellular ER

Rare TREM2-TYROBP pathway variants complement standard PRS by identifying microg

Score: 0.000 · Late-onset Alzheimer's disease · 2026-04-26

We hypothesize that rare loss-of-function variants in microglial-expressed genes within the TREM2-TYROBP signaling casca

Convergent NF-κB enhancers across diverse priming stimuli share therapeutic vuln

Score: 0.000 · Alzheimer's disease · 2026-04-26

Despite different initial triggers (LPS, β-amyloid, aging), primed microglia may converge on a common 'epigenetic primin